<DOC>
	<DOC>NCT00808626</DOC>
	<brief_summary>99mTc-rBitistatin is a radiolabeled polypeptide which is designed to stick to blood clots so that the blood clots can be detected by imaging. The purpose of this trial is to evaluate in patients the safety of 99mTc-rBitistatin and its ability to locate blood clots in the arms and legs.</brief_summary>
	<brief_title>Phase II Investigation of 99mTc-rBitistatin for Imaging Venous Thrombosis</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<criteria>peripheral acute venous thrombosis diagnosed by vascular ultrasound is able to give informed consent is likely to complete the study is pregnant is lactating has a history of prior severe allergic reactions (anaphylactic response) prior use of GP IIb/IIIa antagonist (e.g., abciximab, eptifibatide) has a platelet count &lt;100,000 or history of thrombocytopenia has a history of stroke has a history of recent bleeding documented by decreasing hemoglobin (&gt;1 gm) in last 7 days</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>